Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Frontiers in Medicine|August 25, 2022
Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort studyIvan Castellví, Diego Castillo, Hèctor Corominas, et al.
Infectious Diseases (London, England)|July 11, 2020
Linezolid for therapy of <i>Staphylococcus aureus</i> meningitis: a cohort study of 26 patientsVicente Pintado, Rosario Pazos, Manuel Enrique Jiménez-Mejías, et al.
Plos One|August 30, 2023
Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort studySandra Pérez-Recio, Maria D Grijota-Camino, Luis Anibarro, et al.
The Journal of Infection|November 8, 2015
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in SpainZaira R Palacios-Baena, Jesús Oteo, Carmen Conejo, et al.
Infection|September 26, 2020
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paperIbai Los-Arcos, Gloria Iacoboni, Manuela Aguilar-Guisado, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2023
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trialJesús Sojo-Dorado, Inmaculada López-Hernández, Alicia Hernández-Torres, et al.
BMJ Open Respiratory Research|December 8, 2025
Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocolLaura Diab Casares, Juan Espinosa Pereiro, María Teresa Tórtola Fernández, et al.
JAMA Network Open|January 13, 2022
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical TrialJesús Sojo-Dorado, Inmaculada López-Hernández, Clara Rosso-Fernandez, et al.
Microbiology Spectrum|November 10, 2021
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter StudySandra Pérez-Recio, Natàlia Pallarès, Maria D Grijota-Camino, et al.
Pageof 5